(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

• Published in: Annals of neurology Vol. 80; no. 3; p. 368
• Main Authors: Tiraboschi, Pietro, Corso, Angelo, Guerra, Ugo Paolo, Nobili, Flavio, Piccardo, Arnoldo, Calcagni, Maria Lucia, Volterrani, Duccio, Cecchin, Diego, Tettamanti, Mauro, Antelmi, Luigi, Vidale, Simone, Sacco, Leonardo, Merello, Maria, Stefanini, Stefano, Micheli, Anna, Vai, Paola, Capitanio, Selene, Gabanelli, Sara Vincenzina, Riva, Riccardo, Pinto, Patrizia, Biffi, Ave Maria, Muscio, Cristina
• Format: Journal Article
• Language: English
• Published: United States 01.09.2016
• Subjects: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease - diagnostic imaging; Corpus Striatum - diagnostic imaging; Diagnosis, Differential; Female; Frontotemporal Dementia - diagnostic imaging; Humans; Lewy Body Disease - diagnostic imaging; Male; Middle Aged; Myocardial Perfusion Imaging - methods; Myocardial Perfusion Imaging - standards; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon - methods; Tomography, Emission-Computed, Single-Photon - standards; Tropanes

To compare the diagnostic value of striatal (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane ((123) I-FP-CIT) single photon emission computed tomography (SPECT) and (123) I-metaiodobenzylguanidine ((123) I-MIBG) myocardial scintigraphy in differentiating dementia with Lewy bod...